|

anti-PSMA CAR-NK Clinical Trials

2 actively recruiting trials

Pipeline

Early 1: 2

Top Sponsors

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences2

Indications

  • Prostate Cancer Castration-resistant Prostate Cancer2
  • Cancer2

Other2 trials

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)
Early 1
Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.